Search

Your search keyword '"Buschauer A"' showing total 74 results

Search Constraints

Start Over You searched for: Author "Buschauer A" Remove constraint Author: "Buschauer A" Publisher springer international publishing Remove constraint Publisher: springer international publishing
74 results on '"Buschauer A"'

Search Results

1. Progress in the Discovery of BCR-ABL Kinase Inhibitors for the Treatment of Leukemia

2. Small-Molecule Inhibitors of Bruton’s Tyrosine Kinase

3. Small Molecule Inhibitors of ALK

4. Inhibitors of Vascular Endothelial Growth Factor Receptor

5. Medicinal Chemistry of Plant Naturals as Agonists/Antagonists for Taste Receptors

6. Chemical Activation of Sensory TRP Channels

7. Taste Receptor Gene Expression Outside the Gustatory System

8. Botulinum Neurotoxin, Tetanus Toxin, and Anthrax Lethal Factor Countermeasures

9. Neuronal Functions and Emerging Pharmacology of TAAR1

10. Inhibitors of Histidinol Dehydrogenase

11. Olfactory Transduction Channels and Their Modulation by Varieties of Volatile Substances

12. Chemosensory G Protein-Coupled Receptors (GPCR) in Blood Leukocytes

13. Inhibition and Activity Regulation of Bacterial Collagenases

14. Bacterial Carbonic Anhydrases

15. An Elusive Task: A Clinically Useful Inhibitor of Metallo-β-Lactamases

16. Fungal Carbonic Anhydrases and Their Inhibition

17. Protozoan Carbonic Anhydrases

18. Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors

19. Adenosine A2A Receptor Antagonists

20. Nano-Enabled Delivery of Intracellular Therapeutics

21. Targeting α-Synuclein as a Parkinson’s Disease Therapeutic

22. Personalized Medicine: Where Do We Go from Here?

23. Multimodal Imaging and Theranostic Application of Disease-Directed Agents

25. Barriers in Nanomedicine: The Importance of Defined Chemistry and Engineering Approaches for Clinical Translation

26. Hsp90 Co-chaperones as Drug Targets in Cancer: Current Perspectives

27. Nanoscopic Agents in a Physiological Environment: The Importance of Understanding Their Characteristics

28. Evaluating Dual Hsp90 and Hsp70 Inhibition as a Cancer Therapy

29. Targeting the C-Terminus of Hsp90 as a Cancer Therapy

30. The Effect of Structure and Mechanism of the Hsp70 Chaperone on the Ability to Identify Chemical Modulators and Therapeutics

31. Heat Shock Protein 27: Structure, Function, Cellular Role and Inhibitors

32. HSP47: The New Heat Shock Protein Therapeutic Target

33. Hsp40 Co-chaperones as Drug Targets: Towards the Development of Specific Inhibitors

34. Allosteric Inhibitors of Hsp70: Drugging the Second Chaperone of Tumorigenesis

36. Selenium-Based Drug Design

37. Silicon Mimics of Unstable Carbon

39. Drug Design Based on the Carbon/Silicon Switch Strategy

41. Smoothened, Stem Cell Maintenance and Brain Diseases

42. Smoothened Inhibitors in Cancer

43. The Role of Smoothened and Hh Signaling in Neovascularization

45. Receptor Modifications in Hedgehog Regulation

46. Structure–Activity Relationships and Mechanism of Action of Small Molecule Smoothened Modulators Discovered by High-Throughput Screening and Rational Design

48. Allosteric Modulation of Chemokine Receptors

49. Exploring the CXCR3 Chemokine Receptor with Small-Molecule Antagonists and Agonists

50. Selective and Dual Targeting of CCR2 and CCR5 Receptors: A Current Overview

Catalog

Books, media, physical & digital resources